Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Lung Neoplasms 5Adenocarcinoma of Lung 5Neoplasms 2Brain Neoplasms 2Tumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK) 1Sarcoma 1Rhabdomyosarcoma 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Granuloma, Plasma Cell 1Glioblastoma 1ALK-positive NSCLC 1ALK-positive Advanced Tumors 1

Interventions

Temozolomide 94Radiotherapy 59Bevacizumab 59Radiosurgery 41Carboplatin 27Irinotecan 26Magnetic Resonance Spectroscopy 25Surgical Procedures, Operative 23Etoposide 22Carmustine 20Filgrastim 18Erlotinib Hydrochloride 17Cyclophosphamide 16Cisplatin 16Vincristine 15Lomustine 15Lapatinib 15Sorafenib 13Radiation 13Trastuzumab 12Nivolumab 12Imatinib Mesylate 12Thalidomide 11Surveys and Questionnaires 11Granulocyte Colony-Stimulating Factor 11Radiotherapy, Intensity-Modulated 10Aminolevulinic Acid 10temsirolimus 9Topotecan 9Thiotepa 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Brain Neoplasms × ceritinib × Clear all
NCT02605746 2020-12-11

Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis

St. Joseph's Hospital and Medical Center, Phoenix

Phase EARLY_PHASE1 Completed
10 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT02336451 2020-04-21

Ascend-7

Novartis

Phase 2 Completed
156 enrolled 39 charts
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡